6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01789047 (ClinicalTrials.gov)	March 2013	7/2/2013	Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease	Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease	Idiopathic Parkinson's Disease;Drug Induced Dyskinesia	Drug: Topiramate;Drug: Placebo;Drug: Amantadine	Rush University Medical Center	Michael J. Fox Foundation for Parkinson's Research	Terminated	30 Years	90 Years	All	42	Phase 2	United States
2	NCT00794313 (ClinicalTrials.gov)	September 2009	19/11/2008	Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease	Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease	Parkinson's Disease	Drug: Amantadine 300 mg;Drug: Topiramate;Drug: Sugar Pill	Oregon Health and Science University	NULL	Terminated	21 Years	N/A	All	3	N/A	United States
3	EUCTR2007-002467-27-GB (EUCTR)	24/01/2008	26/11/2007	Antidyskinetic Properties of Topiramate: A Double-Blind, Placebo-Controlled Trial in Patients with P ...	Antidyskinetic Properties of Topiramate: A Double-Blind, Placebo-Controlled Trial in Patients with P ...	Patients with idiopathic Parkinson's disease and levodopa-induced dyskinesias MedDRA version: 13.1;L ...	Product Name: Topiramate INN or Proposed INN: TOPIRAMATE	Salford Royal NHS Foundation Trust	NULL	Not Recruiting			Female: yes Male: yes			United Kingdom
4	NCT00296959 (ClinicalTrials.gov)	September 2004	23/2/2006	Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease	Anti-Dyskinetic Properties of Topiramate: A Double-Blind, Placebo-Controlled Trial in Patients With ...	Parkinson's Disease	Drug: topiramate (drug)	University Health Network, Toronto	NULL	Terminated	30 Years	75 Years	Both	20	Phase 2	Canada

First Previous1Next Last